9 completed. 7 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 7 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Marinomed Biotech AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lubricating Effectiveness of Carragelose Eye Drops in Patients Affected by Mild to Moderate Dry Eye Carragelose - Dry Eye Syndromes | Not applicable | Completed | Marinomed Biotech AG | 30 | 2024-01-15 | 2024-12-09 |
| Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients Carragelose, NaCl - Covid19 | Not applicable | Completed | Marinomed Biotech AG | 14 | 2021-03-08 | 2022-08-29 |
| Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers nasal spray - Respiratory Viral Infection, Common Cold | Not applicable | Completed | Marinomed Biotech AG | 300 | 2020-12-20 | 2022-08-25 |
| Carrageenan Nasal Spray for COVID-19 Prophylaxis Carrageenan nasal and throat spray, Saline nasal and throat spray - COVID-19, SARS-CoV 2 | Not applicable | Completed | Swansea University | 480 | 2020-12-17 | 2023-04-28 |
| Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Common Cold Viruses Coldamaris lozenges - Common Cold, Viral Infection | Not applicable | Completed | Marinomed Biotech AG | 29 | 2020-08-04 | 2021-01-08 |
| Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to Saline Nasal Spray. nasal spray - Allergic Rhinitis, Allergic Rhinoconjunctivitis | Not applicable | Completed | Marinomed Biotech AG | 42 | 2020-08-04 | 2021-02-21 |
| Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis Eye Drops, Solution in Single-Dose Container - Allergic Conjunctivitis, Allergic Rhinitis | Phase 2 | Completed | Marinomed Biotech AG | 64 | 2020-08-04 | 2022-08-25 |
| Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis nasal spray, no treatment - Allergic Rhinitis, Allergic Rhinoconjunctivitis | Not applicable | Completed | Marinomed Biotech AG | 42 | 2020-08-04 | 2021-02-21 |
| Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray Rhinocort, Budesolv, Placebo - Allergic Rhinitis, Allergic Conjunctivitis | Phase 3 | Completed | Marinomed Biotech AG | 82 | 2018-11-19 | 2020-10-12 |
Rhinitis, Allergic (4) · COVID-19 (3) · Common Cold (3) · Conjunctivitis, Allergic (2) · Virus Diseases (2) · Conjunctivitis (1) · Coronavirus Infections (1) · Coxsackievirus Infections (1) · Dry Eye Syndromes (1) · Nasal Obstruction (1) · Pneumonia (1) · Respiratory Aspiration (1) · Rhinitis, Allergic, Seasonal (1) · Severe Acute Respiratory Syndrome (1)
Tobacco Use Cessation Devices (3) · Budesonide (1) · Ophthalmic Solutions (1) · Solutions (1)
Austria (7) · Spain (1) · United Kingdom (1)
Eva Prieschl-Grassauer, PhD (3) · Arschang Valipour, MD (1) · Eva E Prieschl-Grassauer, PhD (1) · Georg-Christian Funk, MD (1) · Iulia Niculescu, MD (1) · Margarita Calogne, PhD (1) · Wolfgang Hoeppler, MD (1) · Zita M Jessop, MBBChir PhD (1)
PMID 34526804, PMID 36109791, PMID 38333020, PMID 39386177, PMID 39534593, PMID 42333311
2018 (1), 2019 (1)